Much of the research done at Magee-Womens Hospital of UPMC and Magee-Womens Research Institute leads to medical breakthroughs that can benefit future generations of patients.
Magee has been home to significant clinical and developmental research, leading to innovations that have been implemented worldwide.
Magee participated in research trials that resulted in advances in the treatment of respiratory failure, such as the use of surfactant to reduce respiratory distress in preterm babies and Inhaled Nitric Oxide (iNO) to treat persistent pulmonary hypertension in the newborn.
Other groundbreaking studies to improve care for premature babies include development of pain assessment and readiness-to-feed tools, and laser eye surgery to reduce or eliminate blindness.
These studies resulted in critical advancements in neonatal care, and current studies continue to keep Magee at the forefront of neonatal research.
There may be occasions when a baby may meet the criteria for selected research studies. When this happens, parents may be asked to give permission for their baby’s participation. All of the details about the study will be explained, and parents are encouraged to ask questions.